Atlas Trials

Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Clinical trial NCT02322866 · COMPLETED

Trial details

NCT number
NCT02322866
Sponsor
Almirall, S.A.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2014-12-03
Primary completion
2017-01-12
Enrollment
1034

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.